Suppr超能文献

T细胞对亚感染性猴免疫缺陷病毒(SIV)的增殖反应与猕猴受到攻击后未被感染相关。

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.

作者信息

Clerici M, Clark E A, Polacino P, Axberg I, Kuller L, Casey N I, Morton W R, Shearer G M, Benveniste R E

机构信息

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland.

出版信息

AIDS. 1994 Oct;8(10):1391-5. doi: 10.1097/00002030-199410000-00004.

Abstract

OBJECTIVES

To analyze correlates of protection in macaques exposed to SIV.

METHODS

Peripheral blood mononuclear cells (PBMC) from macaques inoculated intrarectally with various dilutions of SIV were examined for their in vitro proliferative response to SIV envelope peptides and generation of SIV-specific antibodies. Some macaques previously exposed intravenously to subinfectious doses of SIV were subsequently challenged 16 months later with an infectious intrarectal dose of SIV.

RESULTS

The viral-specific immune responses of macaques exposed to infectious doses of SIV were characterized by generation of antibodies and weak or undetectable T-cell-mediated responses. In contrast, macaques inoculated with doses of SIV below the threshold required for seroconversion and recovery of virus exhibited T-cell proliferation in response to SIV envelope synthetic peptides. The macaques that had previously been exposed to SIV resisted the subsequent virus challenge, whereas the naive macaques (never exposed to SIV) all became infected.

CONCLUSIONS

The inability to productively infect macaques previously exposed to subinfectious doses of SIV suggests that a T-cell-mediated response may confer long-term protection against infection, and that AIDS vaccines should be designed to optimize the cellular arm of the immune response.

摘要

目的

分析感染猴免疫缺陷病毒(SIV)的猕猴体内的保护相关因素。

方法

对经直肠接种不同稀释度SIV的猕猴外周血单个核细胞(PBMC)进行检测,观察其对SIV包膜肽的体外增殖反应以及SIV特异性抗体的产生情况。部分先前经静脉接种亚感染剂量SIV的猕猴,在16个月后经直肠接种感染剂量的SIV进行攻毒。

结果

感染剂量SIV的猕猴的病毒特异性免疫反应表现为产生抗体以及微弱或无法检测到的T细胞介导反应。相比之下,接种低于血清转化和病毒恢复所需阈值剂量SIV的猕猴,对SIV包膜合成肽表现出T细胞增殖反应。先前接触过SIV的猕猴能够抵抗随后的病毒攻击,而未接触过SIV的猕猴(从未接触过SIV)均被感染。

结论

先前接触亚感染剂量SIV的猕猴无法被有效感染,这表明T细胞介导的反应可能提供针对感染的长期保护,并且艾滋病疫苗应设计为优化免疫反应的细胞分支。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验